Filing Flows › Stoke Therapeutics (STOK) › Stock forecast & fair value
Stoke Therapeutics (STOK) stock forecast and price target
Stoke Therapeutics (STOK) trades at $26.54. 13 analysts' median price target is $43.00 (+62%), from $35.00 to $60.00.
Stoke Therapeutics' latest quarter
Stoke Therapeutics, Q3 2026: revenue $11.3M (+6% year over year), operating margin -686.9%, net loss $73.6M, operating cash flow −$62.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for STOK stock?
The median of 13 analysts' 12-month targets is $43.00, +62% from $26.54; the range is $35.00 to $60.00. The average rating is strong buy.
Does Stoke Therapeutics usually beat earnings estimates?
It beat the consensus EPS estimate in 20% of the quarters on record.
Is STOK stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.